Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kenneth Hoberman currently holds 264,935 shares of TG THERAPEUTICS, INC. (TGTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth Hoberman has been a net seller of TGTX stock. They have purchased $126.4K and sold $5.8M worth of shares.
Kenneth Hoberman's most recent insider trade was on Jun 19, 2024, when they sold 22,250 shares at $0.00 per share.
Kenneth Hoberman serves as Executive at TG THERAPEUTICS, INC. (TGTX). They have executed 76 insider transactions totaling $5.9M over their tenure at the company.
Kenneth Hoberman holds the position of Executive at TG THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Kenneth Hoberman has shown a selling trading pattern, with $126.4K in total purchases and $5.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kenneth Hoberman was on Jun 25, 2019, when they sold $384.3K worth of STML shares. This transaction involved 25,500 shares at $15.07 per share.
Kenneth Hoberman currently owns 264,935 shares of TG THERAPEUTICS, INC. (TGTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kenneth Hoberman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kenneth Hoberman has 76 Form 4 filings on record as an insider at TG THERAPEUTICS, INC..
Set alerts for Kenneth Hoberman and 40,000+ other insiders.